A weekly injection pen photographed in a refined specialist clinic setting
Medications

Mounjaro

(Tirzepatide)

Once-weekly injection pen

A once-weekly dual-hormone medicine prescribed within specialist obesity care — never as a stand-alone answer.

UK: licensed for weight management in eligible adults. Chennai: local availability, approved indications and suitability are confirmed individually by the clinic before prescribing.
Your care pathway

How treatment works here

01

It starts with a consultation

Nothing is prescribed without one.

02

A careful clinical assessment

A doctor reviews your medical history, current medicines, conditions and the factors driving your weight before any treatment is recommended.

03

Where treatment is appropriate

It is prescribed following your consultation. In the UK, treatment is dispensed by a licensed pharmacy and delivered to your address anywhere in the UK. In Chennai, it is collected in person from the clinic.

04

Reviewed before every supply

Nothing is issued on repeat without review. Before each supply you tell us how you are getting on, and a doctor reviews how you are responding, how you are tolerating treatment and anything that has changed before deciding.

United Kingdom · Chennai

What's Included

Your Mounjaro Prescription Includes

Doctor-reviewed prescription

Every prescription follows individual review by a doctor and stays under ongoing clinical supervision.

Live online sessions with Dr Raj

Patients are invited to regular online education evenings and live Q&A sessions, covering nutrition, muscle preservation, managing side effects and planning for the long term.

Support between appointments

You can tell us about side effects or concerns at any point between consultations, not only at your next appointment.

How you receive your treatment

In the UK, dispensed by a licensed pharmacy and delivered to your door anywhere in the UK with tracked delivery. In Chennai, collected in person from the clinic.

About the Medication

What is Mounjaro?

Mounjaro contains tirzepatide, a prescription medicine given as a once-weekly injection under the skin. It is licensed in the UK for weight management in adults who meet the criteria, and for type 2 diabetes.

Tirzepatide is a dual agonist: it acts on both the GIP and GLP-1 receptors. A head-to-head trial found greater average weight reduction with tirzepatide than semaglutide. Having two targets does not establish which medicine is best for an individual.

Suitability depends on your medical history, your other medicines, pregnancy plans and the balance of potential benefit and risk — which is exactly what a specialist consultation is for.

How Does It Work?

Dual hormone signalling

Tirzepatide mimics GIP and GLP-1, two gut hormones released after eating that influence appetite, fullness and insulin release.

Slower gastric emptying

Food leaves the stomach more slowly, so fullness lasts longer and post-meal glucose rises more gently.

Better insulin sensitivity

Glucose control often improves early, which is why diabetes and blood-pressure medicines may need adjusting during treatment.

Weekly injection pen with water and eucalyptus
Using the pen

How the weekly pen works

UK Mounjaro comes in a pre-filled multi-dose KwikPen holding four weekly doses. Your nurse or doctor teaches the dose-selection and injection technique before your first use.

  1. Four weekly dosesEach KwikPen holds four doses. Select the prescribed dose before each injection; there is no mixing.
  2. Subcutaneous injectionInjected into the fat layer of the abdomen, thigh or back of the upper arm — not into muscle.
  3. Rotate the siteChange the injection site each week to keep the tissue healthy.
  4. Same day each weekChoose a fixed day; if needed, the day can be moved as long as at least 72 hours have passed.
  5. Safe storage and disposalRefrigerate at 2–8°C before use; after first use, keep below 30°C for up to 30 days. Discard in the sharps bin after dose four or 30 days from first use, whichever comes first.
Clinical Evidence

How Effective is Mounjaro?

In the SURMOUNT-1 trial, adults with obesity taking tirzepatide alongside lifestyle support lost substantially more weight than those on placebo over 72 weeks. Trial averages describe groups, not individuals.

15%
Average reduction at 5mg
19.5%
Average reduction at 10mg
20.9%
Average reduction at 15mg
3.1%
Placebo

SURMOUNT-1, New England Journal of Medicine, 2022. Your own result depends on dose, tolerance, nutrition, activity and long-term support.

Dosing

How Do You Take Mounjaro?

Mounjaro is a once-weekly self-injection. Treatment starts low and increases gradually, normally at four-week intervals, so your body has time to adjust.

Most people find side effects are strongest in the days after a dose increase, which is why escalation is never rushed and always reviewed.

Do not change your dose unless your doctor has told you to.

Available Doses

2.5mg
5mg
7.5mg
10mg
12.5mg
15mg

2.5mg is a starting dose only. Maintenance is individual — some people do best at 5mg, others need to continue escalating.

Who Qualifies?

  • Adults meeting the licensed BMI and health criteria
  • A complete medical and medication review with no identified contraindication
  • Willing to engage with nutrition, activity and monitoring
  • Not pregnant or trying to conceive

Book a consultation

Discuss your care with the clinic that is right for you.

Potential Side Effects

Like all medicines, Mounjaro may cause side effects. Most are mild and settle as your body adjusts. Seek urgent medical help for severe, persistent abdominal pain, especially if it spreads to the back, with or without vomiting.

NauseaVomitingDiarrhoeaConstipationReduced appetiteFatigueIndigestionHeadache

Always read the Patient Information Leaflet. Contact your clinic or your doctor with any concerns.

Read the Mounjaro patient information leaflet
Specialist Indications

How Mounjaro is used across metabolic conditions

Weight rarely travels alone. Below is where tirzepatide fits within each condition we treat, with published evidence you can read for yourself.

Educational scan-style torso with the liver highlighted beneath the ribs

Fatty liver disease (MASLD)

Fat accumulation in the liver that can progress to inflammation and fibrosis if left unaddressed.

Read the condition page

Where Mounjaro fits: Sustained weight reduction is the strongest lever on liver fat; treatment sits alongside liver function tests and FibroScan monitoring.

Published evidence
More than a prescription

The Specialist Weight Management Plan

The Specialist Weight Management Plan is our most intensive option for the most complex cases. Dr Raj recommends it after your initial consultation where it is the right level of support. Not everyone needs it. For others, consultations and review alone are enough, and what you are offered depends on what is actually going on.

Mounjaro FAQs

No. Mounjaro contains tirzepatide, which acts on two hormone pathways (GIP and GLP-1). Ozempic and Wegovy contain semaglutide, which acts on GLP-1 alone. They are not interchangeable and each has its own licensed indications.

Appetite changes are often noticed within the first weeks. Weight reduction is gradual and continues over months as the dose is increased; trial averages were measured at 72 weeks.

Obesity is a long-term condition. Some people continue on a maintenance dose, others taper with a structured plan. That decision is made with your doctor, not by a fixed rule.

No. It must not be used in pregnancy and should be stopped before a planned pregnancy in line with current prescribing guidance.

If fewer than four days have passed you can take it as soon as you remember, then return to your usual day. Otherwise skip it and take the next scheduled dose — never double up.

From the clinic

Clinical Insights

Let's find out what's right for you

Treatment is one option among several, and which one suits you depends on your history, your other conditions and what has been tried before. That is what the consultation is for.